146 related articles for article (PubMed ID: 32391104)
1. Clinical and prognostic association of oncogene cadherin 11 in gastric cancer.
Wang Q; Jia Y; Peng X; Li C
Oncol Lett; 2020 Jun; 19(6):4011-4023. PubMed ID: 32391104
[TBL] [Abstract][Full Text] [Related]
2. Aberrant Cadherin11 expression predicts distant metastasis of gastric cancer.
Mita H; Katoh H; Komura D; Kakiuchi M; Abe H; Rokutan H; Yagi K; Nomura S; Ushiku T; Seto Y; Ishikawa S
Pathol Res Pract; 2023 Feb; 242():154294. PubMed ID: 36610328
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of cadherin-11 for subsequent recurrence and progression in non-muscle invasive bladder cancer.
Chen MK; Chen ZJ; Xiao KH; Qin ZK; Ye YL; Wen WJ; Bian J; Xue KY; Zhou QZ; Guo WB; Zhou JH; Xia M; Li X; Liu CD
Jpn J Clin Oncol; 2020 Apr; 50(4):456-464. PubMed ID: 31894237
[TBL] [Abstract][Full Text] [Related]
4. Combined overexpression of cadherin 6, cadherin 11 and cluster of differentiation 44 is associated with lymph node metastasis and poor prognosis in oral squamous cell carcinoma.
Ma C; Zhao JZ; Lin RT; Zhou L; Chen YN; Yu LJ; Shi TY; Wang M; Liu MM; Liu YR; Zhang T
Oncol Lett; 2018 Jun; 15(6):9498-9506. PubMed ID: 29805672
[TBL] [Abstract][Full Text] [Related]
5. Aberrant methylation of CDH11 predicts a poor outcome for patients with bladder cancer.
Lin YL; Gui SL; Ma JG
Oncol Lett; 2015 Aug; 10(2):647-652. PubMed ID: 26622548
[TBL] [Abstract][Full Text] [Related]
6.
Yuan S; Li L; Xiang S; Jia H; Luo T
Cancer Manag Res; 2019; 11():2517-2529. PubMed ID: 31114321
[No Abstract] [Full Text] [Related]
7. Downregulation of CDH11 Promotes Metastasis and Resistance to Paclitaxel in Gastric Cancer Cells.
Yang Z; Yan C; Yu Z; He C; Li J; Li C; Yan M; Liu B; Wu Y; Zhu Z
J Cancer; 2021; 12(1):65-75. PubMed ID: 33391403
[No Abstract] [Full Text] [Related]
8. Interleukin enhancer-binding factor 3 and HOXC8 co-activate cadherin 11 transcription to promote breast cancer cells proliferation and migration.
Zhang Y; Yang C; Zhang M; Liu H; Gong C; Zhang J; Xu S; Zou J; Kai Y; Li Y
Oncotarget; 2017 Dec; 8(64):107477-107491. PubMed ID: 29296180
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic investigations of PLA2G16 and CDH11 expression levels as independent prognostic markers of human osteosarcoma.
Azarsina S; Otoukesh B; Taheriazam A; Kaghazian M; Boddouhi B; Yahaghi E; Kaghazian P
Arch Med Sci; 2017 Oct; 13(6):1347-1351. PubMed ID: 29181064
[TBL] [Abstract][Full Text] [Related]
10. Cadherin-11 mRNA and protein expression in ovarian tumors of different malignancy: No evidence of oncogenic or tumor-suppressive function.
VON Bülow C; Oliveira-Ferrer L; Löning T; Trillsch F; Mahner S; Milde-Langosch K
Mol Clin Oncol; 2015 Sep; 3(5):1067-1072. PubMed ID: 26623052
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Transcriptional Profiling Cadherin Family and Therapeutic Approaches of Gastric Cancer: A Translational Outlook on Multi-omics Data Analysis.
Wang H; Zhang B
Appl Biochem Biotechnol; 2024 Mar; ():. PubMed ID: 38530538
[TBL] [Abstract][Full Text] [Related]
12. HOXB13 expression and promoter methylation as a candidate biomarker in gastric cancer.
Sui BQ; Zhang CD; Liu JC; Wang L; Dai DQ
Oncol Lett; 2018 Jun; 15(6):8833-8840. PubMed ID: 29928325
[TBL] [Abstract][Full Text] [Related]
13. Cadherin 11 Inhibition Downregulates β-catenin, Deactivates the Canonical WNT Signalling Pathway and Suppresses the Cancer Stem Cell-Like Phenotype of Triple Negative Breast Cancer.
Satriyo PB; Bamodu OA; Chen JH; Aryandono T; Haryana SM; Yeh CT; Chao TY
J Clin Med; 2019 Jan; 8(2):. PubMed ID: 30691241
[TBL] [Abstract][Full Text] [Related]
14. Cadherin dysregulation in gastric cancer: insights into gene expression, pathways, and prognosis.
Wang H; Mazzocca A; Gao P
J Gastrointest Oncol; 2023 Oct; 14(5):2064-2082. PubMed ID: 37969819
[TBL] [Abstract][Full Text] [Related]
15. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
[TBL] [Abstract][Full Text] [Related]
16. Methylation of ASC/TMS1 promoter is associated with poor prognosis of patients with gastric cancer.
Wu L; Zhang C; Wang X; Ding X; Deng J; Liang H
Clin Transl Oncol; 2016 Mar; 18(3):296-303. PubMed ID: 26260914
[TBL] [Abstract][Full Text] [Related]
17. The role of cadherin-11 in microcystin-LR-induced migration and invasion in colorectal carcinoma cells.
Zhu Q; Wang Z; Zhou L; Ren Y; Gong Y; Qin W; Bai L; Hu J; Wang T
Oncol Lett; 2018 Feb; 15(2):1417-1422. PubMed ID: 29399188
[TBL] [Abstract][Full Text] [Related]
18. Expression Status And Prognostic Value Of M6A-associated Genes in Gastric Cancer.
Guan K; Liu X; Li J; Ding Y; Li J; Cui G; Cui X; Sun R
J Cancer; 2020; 11(10):3027-3040. PubMed ID: 32226518
[No Abstract] [Full Text] [Related]
19. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D
World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474
[TBL] [Abstract][Full Text] [Related]
20. Aberrant SOX11 promoter methylation is associated with poor prognosis in gastric cancer.
Xu X; Chang X; Li Z; Wang J; Deng P; Zhu X; Liu J; Zhang C; Chen S; Dai D
Cell Oncol (Dordr); 2015 Jun; 38(3):183-94. PubMed ID: 25801783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
